Procter & Gamble’s Q1 Results Indicate A Revival Of The Giant
The FMCG giant Procter & Gamble (NYSE:PG) reported its Q1’17 earnings on October 25th. P&G’s has seen its net sales decline in the last two fiscal years with CAGR of -6.3%, primarily due to currency headwinds and economic problems in Latin America and China. The Q1 results signal a return in P&G’s growth as the company’s organic sales grew by 3% and net sales remained flat despite tough macro conditions. In comparison, the company’s key competitors Unilever (NYSE:UL) and Kimberly Clark (NYSE: KMB) are struggling to deliver. P&G’s stock jumped marginally after the earnings release, negating the fear which was factored in its price post Unilever’s bleak Q3 results. P&G benefited from the turnaround in China and the continued market growth in its 10 core product segments. Brand portfolio transformation, product innovations and premiumization played a key role in these results. We believe that P&G will continue to benefit from these three strategies in the future to further revive its growth.
See our complete analysis for Procter & Gamble
Q3’16 Highlights:
- Organic sales and volume growth continued in all the five segments in lieu of successful innovation and marketing campaigns.
- Both the U.S. and China, which are the top two markets for P&G, reported 3% and 2% organic sales growth respectively. China has seen a massive turnaround since the growth from the region was -8% in the first half of FY 2016.
- High commodity prices and increasing wages across the developing markets turned out to be a headwind which was likely offset by the organic volume increase across all the segments.
- Is Procter & Gamble Stock Appropriately Priced At $160?
- Should You Pick Procter & Gamble Stock At $155 After A Mixed Q2?
- Is Procter & Gamble Stock Fully Valued At $150?
- Will Procter & Gamble Stock Continue To Rise After 27% Gains In The Ongoing Inflation Shock?
- Should You Buy TMUS Over Procter & Gamble Stock For Better Returns?
- Should You Buy Colgate-Palmolive Stock At $80?
Strategy 1 : Portfolio Transformation and Productivity Improvement
- Under the portfolio transformation program, P&G sold 100 under performing brands to concentrate on 65 of its core brands.
- The benefits of the sale of 41 beauty brands to Coty will start reaping from Q2’17 as the deal has been closed in early October.
- Already, the simplified portfolio and focused attention on core brands has led to a turnaround in organic growth of the key segments such as hair care, baby care, fabric care & grooming.
- Cost savings in the last 5 years from improved productivity and efficiency stood at $7 billion with a target of $10 billion for the next 5 years.
Strategy 2: Product Innovation
- Product improvements are essential to gain the market share and improve customer stickiness.
- Mach 3 razor, which has 55 million customers was upgraded in the quarter for the first time in a decade.
- The new ‘Crest 3D White toothpaste’ was launched which supported the fastest growing Healthcare segment.
- Further product launches have been scheduled for the third and fourth quarter of this fiscal year.
Strategy 3: Premiumization
- Premium products yield higher revenues and better margins compared to the cheaper products.
- SK-II, which is the premium skin care brand led a strong 3% organic sales growth in the beauty segment.
- The launch of new Crest 3D White toothpaste also indicates towards premiumization of the product category.
- P&G’s management declared that it plans to focus only on the top and middle price tiers which have been showing higher growth and profits [1].
See More at Trefis | View Interactive Institutional Research (Powered by Trefis)
Notes: